BofA lowered the firm’s price target on HCA Healthcare (HCA) to $480 from $540 and keeps a Neutral rating on the shares. The firm is “generally more cautious” on hospitals given the policy headwinds and slowing fundamentals, but views HCA as “relatively better positioned to manage through those headwinds” than peers, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target lowered to $530 from $560 at Stephens
- HCA Healthcare files automatic mixed securities shelf
- HCA Healthcare announces proposed public offering of senior notes
- HCA Healthcare price target lowered to $500 from $561 at TD Cowen
- HCA Healthcare price target lowered to $520 from $540 at Oppenheimer